$5.91
5.74% yesterday
NYSE, Jun 13, 10:00 pm CET
ISIN
US34965K1079
Symbol
FTRE

Fortrea Stock price

$5.91
+0.91 18.20% 1M
-14.09 70.45% 6M
-12.74 68.31% YTD
-18.79 76.07% 1Y
-24.19 80.37% 5Y
-24.19 80.37% 10Y
-24.19 80.37% 20Y
NYSE, Closing price Fri, Jun 13 2025
-0.36 5.74%
ISIN
US34965K1079
Symbol
FTRE
Sector
Industry

Key metrics

Market capitalization $567.44m
Enterprise Value $1.68b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 11.58
EV/Sales (TTM) EV/Sales 0.63
P/S ratio (TTM) P/S ratio 0.21
P/B ratio (TTM) P/B ratio 0.66
Revenue growth (TTM) Revenue growth -10.69%
Revenue (TTM) Revenue $2.69b
EBIT (operating result TTM) EBIT $-102.50m
Free Cash Flow (TTM) Free Cash Flow $145.10m
Cash position $101.60m
EPS (TTM) EPS $-8.77
P/E forward negative
P/S forward 0.23
EV/Sales forward 0.67
Short interest 22.62%
Show more

Is Fortrea a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

Fortrea Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Fortrea forecast:

1x Buy
8%
10x Hold
77%
2x Sell
15%

Analyst Opinions

13 Analysts have issued a Fortrea forecast:

Buy
8%
Hold
77%
Sell
15%

Financial data from Fortrea

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
2,686 2,686
11% 11%
100%
- Direct Costs 2,143 2,143
15% 15%
80%
543 543
8% 8%
20%
- Selling and Administrative Expenses 562 562
49% 49%
21%
- Research and Development Expense - -
-
-
-20 -20
116% 116%
-1%
- Depreciation and Amortization 83 83
13% 13%
3%
EBIT (Operating Income) EBIT -103 -103
493% 493%
-4%
Net Profit -790 -790
549% 549%
-29%

In millions USD.

Don't miss a Thing! We will send you all news about Fortrea directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Fortrea Stock News

Neutral
PRNewsWire
about 6 hours ago
LOS ANGELES , June 13, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Fortrea Holdings Inc. ("Fortrea" or the "Company") (NASDAQ: FTRE) have opportunity to lead the securities fraud class action lawsuit.
Neutral
GlobeNewsWire
one day ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Fortrea To Contact Him Directly To Discuss Their Options
Neutral
GlobeNewsWire
one day ago
NEW YORK, June 12, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Fortrea Holdings Inc. (NASDAQ: FTRE).
More Fortrea News

Company Profile

Fortrea Holdings, Inc. engages in the provision of clinical development and commercialization services. It operates under the Clinical Services and Enabling Services Segments. The Clinical Services segment provides services across the clinical pharmacology, clinical development, and other clinical service spectrum utilizing enabling services and technology through multiple delivery models. The Enabling Services segment provides technology solutions directly to customers that streamline complex randomization and optimize the trial drug supply process, while minimizing operational costs and supporting timely and accurate patient dosing. The company was founded on January 31, 2023 and is headquartered in Durham, NC.

Head office United States
CEO Peter Neupert
Employees 16,000
Founded 2023
Website www.fortrea.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today